NovaBridge Biosciences - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US44975P1030
1,48 € ↑0,02 (1,37%)
2026-06-04
DEL PRIS
SecurityDE:0VY / NovaBridge Biosciences - Depositary Receipt (Common Stock)
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership166,616 shares
Latest Disclosed Value $ 409,875
Citadel Advisors Llc ownership in 0VY / NovaBridge Biosciences - Depositary Receipt (Common Stock)

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 166,616 shares of NovaBridge Biosciences - Depositary Receipt (Common Stock) (DE:0VY) valued at $321,569 USD as of March 31, 2026. The entity filed a previous 13F-HR on May 15, 2025 disclosing 0 shares of NovaBridge Biosciences - Depositary Receipt (Common Stock). The current value of the position is $246,592 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (0VY) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:0VY / NovaBridge Biosciences - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NOVABRIDGE BIOSCIENCES SPONSORED ADS 44975P103 166,616 166,616 410 0.0001
2025-05-15 2025-03-31 13F I MAB SPONSORED ADS 44975P103 0 -931 -100.00 0 0.0000
2025-02-14 2024-12-31 13F I MAB SPONSORED ADS 44975P103 931 -97,458 -99.05 1 -100.00 0.0000
2024-11-14 2024-09-30 13F I MAB SPONSORED ADS 44975P103 98,389 59,681 154.18 122 90.63 0.0000
2024-08-14 2024-06-30 13F I MAB SPONSORED ADS 44975P103 38,708 38,708 65 0.0000
2024-05-15 2024-03-31 13F I MAB SPONSORED ADS 44975P103 0 -74,029 -100.00 0 -100.00
2024-02-14 2023-12-31 13F I MAB SPONSORED ADS 44975P103 74,029 74,029 141 0.0000
2023-11-14 2023-09-30 13F I MAB SPONSORED ADS 44975P103 0 -485 -100.00 0 -100.00
2023-08-14 2023-06-30 13F I MAB SPONSORED ADS 44975P103 485 -109,822 -99.56 1 -99.74 0.0000
2023-05-15 2023-03-31 13F I MAB SPONSORED ADS 44975P103 110,307 -80,326 -42.14 382 -52.14 0.0001
2023-02-14 2022-12-31 13F I MAB SPONSORED ADS 44975P103 190,633 -437,074 -69.63 797 -68.38 0.0002
2022-11-14 2022-09-30 13F I MAB SPONSORED ADS 44975P103 627,707 602,966 2,437.11 2,517 798.93 0.0006
2022-08-15 2022-06-30 13F I MAB SPONSORED ADS 44975P103 24,741 24,741 280 0.0001
2022-05-16 2022-03-31 13F I MAB SPONSORED ADS 44975P103 0 -29,130 -100.00 0 -100.00
2022-02-14 2021-12-31 13F I MAB SPONSORED ADS 44975P103 29,130 -20,116 -40.85 1,380 -61.34 0.0003
2021-11-15 2021-09-30 13F I MAB Depository Receipt 44975P103 49,246 40,018 433.66 3,570 360.65 0.0007
2021-08-16 2021-06-30 13F I MAB SPONSORED ADS 44975P103 9,228 4,084 79.39 775 211.24 0.0002
2021-05-21 2021-03-31 13F/A-1 I MAB SPONSORED ADS 44975P103 5,144 -71,847 -93.32 249 -93.14 0.0001
2021-05-17 2021-03-31 13F I MAB SPONSORED ADS 44975P103 5,144 -71,847 249 0.0001
2021-02-16 2020-12-31 13F I MAB SPONSORED ADS 44975P103 76,991 76,991 3,630 0.0009
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F NOVABRIDGE BIOSCIENCES SPONSORED ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-17 2025-12-31 13F NOVABRIDGE BIOSCIENCES SPONSORED ADS Call 10,000 -3.85 40 0.00 n/a n/a n/a
2025-11-14 2025-09-30 13F I MAB SPONSORED ADS Call 10,400 1.96 39 62.50 n/a n/a n/a
2025-08-14 2025-06-30 13F I MAB SPONSORED ADS Call 10,200 -49.00 25 50.00 n/a n/a n/a
2025-05-15 2025-03-31 13F I MAB SPONSORED ADS Call 20,000 16 n/a n/a n/a
2025-02-14 2024-12-31 13F I MAB SPONSORED ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F I MAB SPONSORED ADS Call 56,400 1,780.00 70 1,280.00 n/a n/a n/a
2024-08-14 2024-06-30 13F I MAB SPONSORED ADS Call 3,000 -74.79 5 -77.27 n/a n/a n/a
2024-05-15 2024-03-31 13F I MAB SPONSORED ADS Call 11,900 2,280.00 22 n/a n/a n/a
2024-02-14 2023-12-31 13F I MAB SPONSORED ADS Call 500 -94.05 1 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F I MAB SPONSORED ADS Call 8,400 -13.40 11 -62.07 n/a n/a n/a
2023-08-14 2023-06-30 13F I MAB SPONSORED ADS Call 9,700 -22.40 29 -32.56 n/a n/a n/a
2023-05-15 2023-03-31 13F I MAB SPONSORED ADS Call 12,500 -30.94 43 -42.67 n/a n/a n/a
2023-02-14 2022-12-31 13F I MAB SPONSORED ADS Call 18,100 66.06 76 70.45 n/a n/a n/a
2022-11-14 2022-09-30 13F I MAB SPONSORED ADS Call 10,900 -51.98 44 -82.88 n/a n/a n/a
2022-08-15 2022-06-30 13F I MAB SPONSORED ADS Call 22,700 -69.12 257 -78.48 n/a n/a n/a
2022-05-16 2022-03-31 13F I MAB SPONSORED ADS Call 73,500 593.40 1,194 137.85 n/a n/a n/a
2022-02-14 2021-12-31 13F I MAB SPONSORED ADS Call 10,600 3.92 502 -32.07 n/a n/a n/a
2021-11-15 2021-09-30 13F I MAB Depository Receipt Call 10,200 -15.00 739 -26.61 n/a n/a n/a
2021-08-16 2021-06-30 13F I MAB SPONSORED ADS Call 12,000 1,007 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F NOVABRIDGE BIOSCIENCES SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-17 2025-12-31 13F NOVABRIDGE BIOSCIENCES SPONSORED ADS Put 39,500 -6.62 157 -1.26 n/a n/a n/a
2025-11-14 2025-09-30 13F I MAB SPONSORED ADS Put 42,300 160 n/a n/a n/a
2025-08-14 2025-06-30 13F I MAB SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F I MAB SPONSORED ADS Put 13,300 -8.28 11 -16.67 n/a n/a n/a
2025-02-14 2024-12-31 13F I MAB SPONSORED ADS Put 14,500 150.00 12 71.43 n/a n/a n/a
2024-11-14 2024-09-30 13F I MAB SPONSORED ADS Put 5,800 205.26 7 133.33 n/a n/a n/a
2024-08-14 2024-06-30 13F I MAB SPONSORED ADS Put 1,900 -45.71 3 -50.00 n/a n/a n/a
2024-05-15 2024-03-31 13F I MAB SPONSORED ADS Put 3,500 2.94 7 0.00 n/a n/a n/a
2024-02-14 2023-12-31 13F I MAB SPONSORED ADS Put 3,400 -73.23 6 -62.50 n/a n/a n/a
2023-11-14 2023-09-30 13F I MAB SPONSORED ADS Put 12,700 38.04 17 -40.74 n/a n/a n/a
2023-08-14 2023-06-30 13F I MAB SPONSORED ADS Put 9,200 2.22 28 -12.90 n/a n/a n/a
2023-05-15 2023-03-31 13F I MAB SPONSORED ADS Put 9,000 125.00 31 93.75 n/a n/a n/a
2023-02-14 2022-12-31 13F I MAB SPONSORED ADS Put 4,000 17 n/a n/a n/a
2022-08-15 2022-06-30 13F I MAB SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F I MAB SPONSORED ADS Put 10,900 -41.08 177 -79.82 n/a n/a n/a
2022-02-14 2021-12-31 13F I MAB SPONSORED ADS Put 18,500 -21.94 877 -48.95 n/a n/a n/a
2021-11-15 2021-09-30 13F I MAB Depository Receipt Put 23,700 -1.66 1,718 -15.08 n/a n/a n/a
2021-08-16 2021-06-30 13F I MAB SPONSORED ADS Put 24,100 2,023 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.